watchAnecdotalFeb 24, 2026
Growth-hormone peptide mainstreaming
GHRP-2 is discussed in mainstream wellness coverage as part of the growth-hormone and anti-aging peptide cluster.
TIMEhigh confidencemedia
Source GHRP-2
Growth Hormone Releasing Peptide-2 · Pralmorelin
Growth HormoneNot ApprovedAnimalResearchSubQ
Popular for:Potent GH release, appetite stimulation, body composition
0
Registered Trials
56
Trial Publications
203
PubMed References
Animal
Evidence Level
Overview
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that potently stimulates growth hormone release through the ghrelin receptor. The short version: people usually care about it for potent gh release, appetite stimulation, body composition, but the strength of the evidence depends heavily on indication and study type.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that potently stimulates growth hormone release through the ghrelin receptor. It produces one of the strongest GH pulses among the GHRP family, with significant effects on appetite stimulation, cortisol, and prolactin.
Developed as a research tool for studying GH secretion, GHRP-2 has been studied in clinical settings for GH deficiency and cachexia. It is more potent than GHRP-6 but less selective than Ipamorelin.
Research Snapshot
What the evidence says
AnimalGHRP-2 currently shows 0 registered trials from ClinicalTrials.gov, 56 PubMed trial publications (42 RCT-tagged), and 203 PubMed references matching the stored source query. Treat PubMed references as literature surface area, not a count of clinical trials.
Known vs uncertain
Known signals
- 0 registered trials are tracked from ClinicalTrials.gov intervention records.
- 56 PubMed clinical-trial publications are indexed.
- 42 PubMed randomized controlled trial publications are indexed.
- 203 PubMed references are tracked separately from trial counts and can include animal, in-vitro, review, mechanism, or clinical records.
Open questions
- Evidence strength may vary by indication, route, formulation, and population.
- Public anecdotes can highlight interest or concern but do not establish clinical efficacy.
- Regulatory status and compounding access can change independently from the research literature.
Mechanism of Action
GHRP-2 acts as a ghrelin mimetic, binding to GHS-R1a receptors in both the pituitary and hypothalamus to stimulate GH release.
Key Research Benefits
One of the most potent GH-releasing peptides
Studied for significant GH elevation in clinical trials
Researched for anti-aging and body composition
Appetite stimulation (may benefit underweight research subjects)
Synergistic when combined with GHRH analogs like CJC-1295
Clinical Evidence Summary
Research Pipeline
Preclinical
Animal
Phase I
Phase II
Phase III
Approved
0
Registered Trials
56
Trial Publications
42
RCT Publications
203
PubMed References
ClinicalTrials.govPubMed ESearchExact-name queryChecked May 3, 2026
Registered trials are ClinicalTrials.gov intervention records. Trial publications are PubMed records tagged as clinical trials or randomized controlled trials. PubMed references are broader source-query matches and can include animal studies, in-vitro work, reviews, mechanism papers, and trial publications.
0
Registered trials
56
Trial publications
42
RCT publications
203
PubMed references
17
Reviews
0
Meta-analyses
Registered trials source
Jun 1, 2026
GHRP-2
Uses the exact compound name as a ClinicalTrials.gov intervention query.
View sourceNot FDA-approved. Research compound. Used in clinical studies for GH deficiency. FDA Category 2 status under review.
Key PubMed References
203 PubMed references · showing top 25 by relevance
View all on PubMedOn the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.
Review
Reverter-Branchat G, Segura J, Pozo OJ · Drug testing and analysis · 2021
PMID: 33197153Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial.
Review
Popławska M, Błażewicz A · Drug testing and analysis · 2019
PMID: 30051972Laparoscopic Sleeve Gastrectomy Resolves Low GHRP-2-Stimulated Growth Hormone Levels in Obese Patients.
Human Study
Ohara E, Tokuyama H, Kitamoto T, et al. · Obesity surgery · 2017
PMID: 28623445Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.
Review
Hu R, Wang Z, Peng Q, et al. · PloS one · 2016
PMID: 26894743Detection of GHRP-2 and GHRP-6 in urine samples from athletes.
Review
Cox HD, Hughes CM, Eichner D · Drug testing and analysis · 2015
PMID: 25809000Anecdotes & Sentiment
Public discussion, not clinical evidence
This section summarizes what people are talking about in public sources. It can be useful for spotting questions, hype cycles, and recurring concerns, but it is separate from the evidence sections above.
Side Effects & Safety
- Increased appetite and hunger - Elevated cortisol levels - Elevated prolactin levels - Water retention - Potential insulin resistance with prolonged use
Increased appetite and hunger
Elevated cortisol levels
Elevated prolactin levels
Water retention
Potential insulin resistance with prolonged use
Known Interactions
No curated interaction entry is live for GHRP-2 yet.
Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.
Comparison Pages
Frequently Asked Questions
Research Disclaimer
This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Regulatory status can vary by compound, formulation, indication, and jurisdiction. Check official labeling, registry records, and qualified professional guidance before making any health-related decision. The studies referenced are linked to their original PubMed sources for verification.